Cancer Grand Challenges: Embarking on a new era of discovery

View this email in your browser

Cancer Grand Challenges February Newsletter

Dear Voornaam,

We hope youre well and settling into 2021. As the new year progresses, were excited to see the developments of the Cancer Grand Challenges community. Despite the obstacles the pandemic has presented, our current 7 teams have continued to push forward with their vital work in tackling some of cancers toughest challenges.

In this months newsletter, read about some of our teams' recent discoveries including new findings on KRAS-driven colorectal cancer and new technology that can create nanoscale-resolution genomic maps of tumour samples. Members of our scientific committee also continue our Challenge blog series reflecting on where a global, multidisciplinary team could take us with each challenge.

Are you ready to take on one of our challenges?

Its just over 6 weeks until the deadline for expressions of interest for the next round of Cancer Grand Challenges. If you are a researcher interested in applying, please read our Expressions of Interest Guidelines. We encourage you to submit your interest by 1 April 2021.

 

Best wishes,

The Cancer Grand Challenges team
 
Pre-application webinar

PRE-APPLICATION WEBINAR

Last month we held a virtual event featuring all the information you need to know about applying to Cancer Grand Challenges and a live Q&A session. If you were unable to join, you can now watch the recording.

 
Watch the webinar
 

LATEST NEWS AND PUBLICATIONS
IMAXT
 

Expansion Sequencing technology

In a new Science paper, members of the IMAXT team announce ExSeq new technology that can create nanoscale-resolution genomic maps of tumour samples.

Read more
Rosetta image
 

Uncovering the role of SLC7A5 in KRAS-driven colorectal cancer

New findings in Nature Genetics from the Rosetta team have identified the antiporter SLC7A5 as a target for KRAS-driven colorectal cancer.

Read more
Ned Sharpless and Iain Foulkes
 

Embarking on a new era of discovery

In a commentary article for AACR Cancer Discovery In Focus, Dr Iain Foulkes and Dr Ned Sharpless discuss the 9 new Cancer Grand Challenges open for application.

Read more
 

LATEST BLOGS
Karen Vousden
 

Challenge blog series

Professor Karen Vousden discusses the normal phenotypes challenge.

Read more
Professor Nic Jones on dormancy
 

Challenge blog series

Professor Nic Jones shares his thoughts on the dormancy challenge.

Read more
Ed Harlow
 

Challenge blog series

Professor Ed Harlow discusses the inflammation challenge.

Read more
 
 
 
Registered with Fundraising Regulator

If you'd rather not receive this in the future, please opt out here:

You are playing a crucial role in helping us beat cancer sooner, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.

Your details are safe with us. Check out our Privacy Policy.

Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.

This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.